Why Tablet Markings, Shapes and Colors Differ

Nov 20, 2026

Leave a message

 

Tablet markings, shapes and colors serve several purposes: they help distinguish products, reflect how a tablet is formed and finished, and can influence the experience of swallowing it. Letters or numbers can contribute to identification, while a coating can change the surface and color. These features do not form a universal code for a medicine's ingredient, strength or release behavior. If a familiar medicine looks different, compare the labeled product details and ask the dispensing pharmacist to confirm it rather than guessing from appearance.

For the production background, SED Pharma's tablet manufacturing solution connects the main stages. A tablet film coating machine belongs to the finishing stage: it applies a layer to a tablet core that already has its basic outline. Understanding that distinction helps explain why shape, color and markings carry different kinds of information.

Key takeaway: Appearance is a set of clues. Product labeling and professional confirmation establish what those clues mean for a particular medicine.

Why tablet shapes and sizes vary

A tablet's outline is a design choice shaped by the formulation, the amount of material in each unit and the intended use. Tablets contain the active ingredient plus supporting ingredients, so a larger tablet does not automatically contain a stronger dose. Comparing the size of two unrelated medicines tells you little about their potency.

For a compressed tablet, the die defines the outline and the punch faces form its surfaces. A round tablet and an oblong tablet therefore start with different tooling geometry. A capsule-shaped tablet is still a tablet; its outline does not turn it into a two-piece capsule. The broader sequence is explained in how tablets are made.

Shape is also connected to usability. Physical differences can affect swallowing and how readily a tablet is accepted. Shape, size and surface characteristics matter together; an oblong outline alone cannot guarantee that a product will be easy for every person to swallow. A swallowing problem should be discussed with a pharmacist or prescriber before changing how a medicine is taken.

What tablet color and coating can tell you

Color can help distinguish presentations within a product range, but there is no universal rule that a particular color means a particular ingredient or strength. A white tablet is not automatically mild, and a darker tablet is not automatically stronger. Color must be interpreted against the exact product's labeling.

Color may come from the tablet core or an applied coating. A film layer can provide a recognizable appearance and, depending on the formulation, contribute to taste masking or surface properties. Some coatings have a specific release function. Looking at a shiny or colored surface cannot establish which purpose applies. For that separate distinction, read film-coated versus enteric-coated tablets.

Approved generic medicines may differ slightly in appearance from the corresponding brand product. An appearance change can accompany a change of manufacturer, and some inactive ingredients can differ. That does not mean a person should decide that any different-looking tablet is an acceptable replacement. The pharmacy should confirm the actual product, strength and dosage form.

Tablet markings: codes, logos and score lines

Letters, numbers and logos are identification features. On a compressed tablet, a suitable punch face can form a recessed or raised feature; some finished products receive a printed marking. The marking belongs to the product design, rather than being a readable description of every ingredient. A number should not be assumed to state the dose unless the product information confirms it.

In the United States, 21 CFR 206.10 in the 2024 CFR edition describes code imprints used with size, shape and color to identify solid oral drug products and their manufacturer or distributor, subject to exemptions. This is a US requirement with a defined scope; marking practices and requirements elsewhere may differ. A visible code by itself also does not prove that a loose tablet is authentic.

A score line is a different feature from an identification code. It may support subdivision for a product evaluated and labeled for that use, but a line alone is not permission to split. The product labeling and a healthcare professional should be consulted about whether a particular tablet can be split. Splitting or crushing can change the performance of some medicines, so neither shape nor a groove should replace the product-specific instructions.

When a familiar tablet looks different

First keep the tablet with its original packaging and label. Then compare the medicine name, strength and dosage form with the previous supply, and note any difference in the manufacturer information and markings. Finally, ask the dispensing pharmacist to confirm an unexplained change before taking the changed tablet. Describe a visible change as an observation, not as a diagnosis of its cause.

Observation Possible explanation Confirmation and next step
Different shape or color in a new refill A different manufacturer or presentation is possible. Ask the pharmacy to verify the dispensed product against the prescription and label.
Unexpected letters, numbers or an unreadable code The product may differ, or the mark may be obscured or damaged. Keep the package and show both tablet faces to the pharmacist; do not guess from a partial code.
New spots, fading, cracks or crumbling Storage exposure or physical damage is possible; appearance cannot establish the cause. Retain the pack and batch details and obtain product-specific advice before using the affected units.
A groove or score line Subdivision may have been intended, but the line is insufficient evidence. Check the exact product instructions with a pharmacist before splitting.

A loose, unidentified tablet has lost useful context. Keep it separate and seek professional identification rather than matching it to a picture and taking it. Conversely, a tablet that looks normal is not proof of correct storage, authenticity or suitability for use. The pack, label and supply source remain essential context.

How the finished appearance connects to production

For a manufacturer, the intended appearance must be translated into a defined tablet design and a controlled process. Compression forms the core; coating adds the specified layer; any printing adds the designated surface information. Inspection then checks the relevant appearance attributes against approved requirements. These are related operations, but they are not interchangeable.

tablet-film-coating-system

SED Pharma tablet film coating machine. 

A useful manufacturing discussion starts with the tablet drawing, desired surface finish and acceptance requirements. If a change affects product quality, its assessment belongs within the site's SOPs, risk assessment and approved validation procedures. This overview supplies no universal coating settings or tooling limits. SED Pharma can use the proposed product information to discuss the equipment stages involved; product-specific studies establish whether the resulting medicine meets its requirements.

Tablet markings, color and shape make more sense when viewed as separate design features. Together they can help distinguish products, but they cannot independently establish the identity, strength or permitted handling of a medicine. For an unexpected change, return to the label and the dispensing pharmacist.

Planning a tablet's finished appearance?

Share your tablet drawing or sample photos, dimensions, intended coating function, marking method, batch size and appearance acceptance criteria with SED Pharma for an initial process-to-equipment review. These inputs help connect the tablet concept to forming and finishing stages. For questions about a medicine you take, consult the dispensing pharmacist.